Pfizer Inc. and BioNTech’s mRNA vaccine candidate, BNT162b2, against COVID-19, was found to be safe and effective, according to the latest analysis by the US Food...
FDA Confirms Pfizer Vaccine 95% Effective, Warns Of 'Severe Adverse Reactions' After Dose 2 Tyler Durden Tue, 12/08/2020 - 08:07 Pfizer and partner BioNTech’s COVID-19 vaccine...
Science Applications International delivered better-than-anticipated earnings for the third quarter of fiscal 2021 (ended Oct. 30) but lagged analysts’ revenue estimates. Shares rose 3.3% on Dec....
Moscow Has Begun First Ever "Large-Scale" COVID Vaccinations Saturday Tyler Durden Sat, 12/05/2020 - 12:45 Russian officials have announced that mass distribution of the Sputnik V vaccine...
Moderna Inc. expects to have between 100 million and 125 million doses of the company's Covid-19 vaccine available globally in the first quarter of 2021.
Trading and Investment Solutions in 2021 The global pandemic has disrupted economic systems around the world. In 2020, lingering lockdowns caused skyrocketing employment. Millions of consumers...
AstraZeneca Plc will likely get results of the company's U.S. Covid-19 vaccine trial in late January 2021 and could potentially file for an emergency authorization, the...
Pfizer Asks EU To Approve COVID-19 Vaccine, Aims For Rollout Before Year's End Tyler Durden Tue, 12/01/2020 - 07:12 Not to be one-upped by Moderna once...
First on CNBC: CNBC Transcript: Moderna CEO Stephane Bancel Speaks with CNBC’s “Squawk Box” today, about protection against severe Covid-19 at 100% efficacy. Q3 2020 hedge...
Moderna Applies For Emergency COVID Vaccine Approval In US & Europe Tyler Durden Mon, 11/30/2020 - 07:20 In a repeat of the last three Mondays, positive...
Ten Covid-19 vaccines could be available by the middle of 2021 if they win regulatory approval, but their inventors need patent protection, the head of the...
There are few companies that thrive even amid challenging conditions because of the strength of their business models and their ability to quickly adapt to evolving...
The Walt Disney Company announced that it is raising its layoff plans for its parks, experiences and products segment amid the pandemic. The mass media and...
AstraZeneca may have tried a positive spin on the trial mistake that led to the accidental discovery of The post Concerns emerge after AZ’s lucky vaccine...
There’s a whole universe of stocks to invest in, but with a little bit of research, we can determine the top 10 stocks Americans want to...
Moderna has inked a deal to supply European Union countries with up to 160 million doses of its COVID-19 vaccine candidate. The supply deal comes after...
The following post will attempt to provide an overview of bitcoin‘s current status. Please note that although we have made an effort to include relevant and...
Moderna will charge governments between $25 and $37 per dose of the company's Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told...
Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency Use Authorization (EUA) by the US Food and...
FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients
AstraZeneca COVID-19 Vaccine Shows Immune Response In Elderly
Final Results Show Pfizer COVID-19 Vaccine 95% Effective
"Sell The Vaccine": Euphoric Wall Street Goes "Full Bull" As Optimism Hits 20 Year High, Prompting BofA To Turn Bearish
BioNTech, Fosun Pharma Get Green Light To Start Covid-19 Vaccine Trial In China
Inovio Gets FDA Go-Ahead To Initiate Covid-19 Vaccine Trial; Shares Rise 11%
COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets
Disney loses $2.8 billion amid pandemic but improves forecasts
US Open – US stocks rally on vaccine hopes and 2021 bets, PPI decelerates, Brexit, Oil slides, Gold surges
Qiagen Kicks Off Sale Of Rapid Covid-19 Test In US; Shares Gain
Pfizer-BioNTech Win EU Covid-19 Vaccine Supply Deal